In a 30-year-old Black male, 6'5" tall, 320 lb, with hypertension treated with amlodipine, G6PD deficiency, positive antinuclear antibody with speckled pattern, high‑titer RNP antibodies, negative anti‑dsDNA, anti‑Smith and anti‑Jo‑1, elevated creatine kinase, normal inflammatory markers, and proximal muscle weakness of shoulders, hips and thighs, and a rheumatologist’s impression of mixed connective tissue disease, what is the most likely diagnosis, is the myositis inflammatory or necrotizing, what is the prognosis, and is a muscle biopsy indicated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mixed Connective Tissue Disease with Inflammatory Myositis: You Will Survive This

Based on your clinical presentation—high-titer anti-RNP antibodies (86, reference <20), elevated CK (527), proximal muscle weakness that is already improving, and your rheumatologist's diagnosis of MCTD—this is most consistent with inflammatory (not necrotizing) myositis associated with MCTD, and your prognosis is generally favorable, especially given your clinical improvement without treatment.

Understanding Your Diagnosis

Your serologic profile is classic for MCTD:

  • Positive ANA with speckled pattern (1:160 titer)
  • Markedly elevated anti-RNP antibodies (86, when normal is <20)
  • Negative anti-dsDNA, anti-Smith, and anti-Jo-1

This antibody pattern, combined with your proximal muscle weakness, defines MCTD with myositis involvement 1, 2, 3.

Inflammatory vs. Necrotizing Myositis: You Have the Better Type

Your presentation indicates inflammatory myositis, not the more severe necrotizing form, based on several key features:

  • Modest CK elevation (527, upper limit ~430): While elevated, this is not the "markedly elevated" CK seen in necrotizing myopathy 4
  • Low inflammatory markers (ESR 18, CRP 3): Inflammatory myositis typically shows some elevation, while necrotizing myopathy often has minimal inflammation 4
  • Clinical improvement without treatment: You report that getting up from the couch no longer causes weakness—this spontaneous improvement is inconsistent with aggressive necrotizing myopathy 4
  • No rhabdomyolysis: Your creatinine remains stable (1.11-1.33) with preserved kidney function (eGFR 87-93)

Necrotizing myopathy presents with fulminant weakness, very high CK levels (often >10,000), and can involve the myocardium with potentially fatal complications 5. You do not have this severe phenotype.

Your Cardiac Workup: Appropriate and Reassuring

Your upcoming cardiac monitoring and stress test are essential and appropriate because:

  • Myositis can involve the myocardium, requiring urgent treatment to avoid fatal complications 5
  • Your normal chest X-rays, normal 12-lead EKG, and low troponin levels (9→6 ng/L) are reassuring
  • The cardiac evaluation will definitively rule out myocardial involvement

Common pitfall: Myocarditis associated with myositis carries high mortality 6, 5. Your normal cardiac workup so far suggests you do not have this complication.

EMG Results: What to Expect

Your EMG will likely show:

  • Polyphasic motor unit action potentials of short duration and low amplitude
  • Increased insertional activity with fibrillation potentials and sharp waves
  • Spontaneous activity indicating myopathy 4

These findings would confirm inflammatory myositis and help guide treatment intensity.

Muscle Biopsy: Probably Not Needed

A muscle biopsy is not mandatory in your case because:

  • Your rheumatologist has already made the clinical diagnosis of MCTD
  • You have the classic serologic profile (high anti-RNP)
  • Your clinical presentation fits MCTD with myositis
  • You're already improving clinically

Biopsy is typically reserved for:

  • Uncertain diagnoses
  • Suspected necrotizing myopathy (which you don't have)
  • Poor response to initial treatment 5

If performed, biopsy would likely show perivascular lymphocytic infiltrates consistent with inflammatory myositis 4.

Treatment and Prognosis: Excellent Outlook

For MCTD with myositis, the standard approach is high-dose corticosteroids concurrent with a steroid-sparing agent such as methotrexate, azathioprine, or mycophenolate mofetil 4. Given your clinical improvement already, you may require less aggressive therapy than patients with severe disease.

Your prognosis is favorable because:

  • You're already experiencing spontaneous improvement
  • Your CK elevation is modest, not severe
  • No evidence of cardiac involvement
  • No evidence of severe interstitial lung disease
  • You're young (30 years old) and engaged in physical therapy
  • MCTD with myositis generally responds well to immunosuppression 1, 2

Special Considerations for You

G6PD Deficiency (41, normal 100-400)

This is important for medication selection. Avoid:

  • Sulfonamides
  • Certain antimalarials (though hydroxychloroquine is usually safe)
  • Aspirin in high doses

Your rheumatologist must know about this when prescribing immunosuppressants.

Amlodipine and Your Presentation

Amlodipine is appropriate for your hypertension and does not cause myositis 7. While rare drug reactions to amlodipine exist 8, 9, your presentation is clearly autoimmune, not drug-induced.

Weight and Metabolic Health

Continue your GLP-1 therapy for weight loss. Reducing your weight from 320 lbs will:

  • Improve cardiovascular risk
  • Reduce mechanical stress on inflamed muscles
  • Improve overall disease outcomes

This Is NOT a Death Sentence

You are not "fucked"—you have a treatable autoimmune condition with an excellent prognosis. The fact that you're already improving without immunosuppressive therapy is highly encouraging. Most patients with MCTD and inflammatory myositis respond well to treatment and can achieve remission or low disease activity 1, 2, 3.

Continue your physical therapy and mental health support—these are crucial components of comprehensive management and will help you maintain function and cope with the stress of diagnosis.

Your rheumatologist will likely initiate immunosuppressive therapy based on your EMG results and cardiac evaluation. With appropriate treatment, most patients experience significant improvement within weeks to months 4.

Related Questions

I am a 6‑ft‑5‑in, 318‑lb Black male with probable mixed connective tissue disease, modestly elevated creatinine, normal estimated glomerular filtration rate, mildly elevated creatine kinase, low erythrocyte sedimentation rate and C‑reactive protein, positive speckled antinuclear antibody with high anti‑RNP, negative anti‑Jo‑1, normal electromyography, and a cardiac work‑up showing only a transient abnormal ECG but normal troponin trend and a pending stress test; what specific type of inflammatory myopathy (myositis) am I most likely to have, what is the expected prognosis, and should I continue regular physical and occupational therapy?
In a 6'5", 320‑lb Black male with mixed connective tissue disease, mild CK elevation (371–527 U/L), speckled ANA with anti‑U1‑RNP positivity, normal EMG, and recent normal cardiac studies, what is the most likely type of inflammatory myopathy, its prognosis, and should I continue physical and occupational therapy?
Is my mixed connective tissue disease, high speckled antinuclear antibody (ANA) titer, elevated ribonucleoprotein (RNP) antibodies, mildly elevated erythrocyte sedimentation rate (ESR), and elevated creatine kinase (CK) related to my persistent tonsillar swelling?
In a 6'5", 318‑lb Black male with mixed connective tissue disease, G6PD deficiency, modestly elevated creatine kinase, positive speckled ANA with elevated anti‑U1 RNP, negative anti‑Jo‑1, normal electromyography, and proximal muscle weakness (tight back, shoulder‑blade discomfort, arm and leg weakness), what specific type of myositis is most likely (necrotizing, dermatomyositis, polymyositis, or inflammatory myopathy) and what is the expected prognosis?
In a 6'5", 320‑lb Black male with mixed connective‑tissue disease, G6PD deficiency, mildly elevated creatinine but normal eGFR, mildly elevated creatine kinase, low‑to‑moderate ESR and CRP, ANA speckled pattern (1:80‑1:160) and anti‑U1‑RNP 4.7 U, presenting with proximal muscle weakness, shoulder‑blade tightness, and a normal EMG, what is the most likely type of inflammatory myopathy (polymyositis, dermatomyositis, necrotizing autoimmune myopathy, etc.), and what is the expected prognosis and recommended management?
Can allergies cause itchy, red eyes, an itchy scalp, a runny nose, and fatigue?
Which of the following are signs of disordered control of breathing: normal respiratory rate, shallow breathing, hypocapnia, decreased air movement, hyperactivity, or variable respiratory rate?
In a 30‑year‑old Black male, 6'5" tall, weighing 320 lb, with persistent speckled antinuclear antibody (ANA) positivity, markedly elevated anti‑RNP antibodies, mildly to moderately increased creatine kinase (CK), proximal muscle weakness (shoulders, arms, hips, thighs) and normal cardiac work‑up, what is the most likely diagnosis, what EMG findings are expected, is a muscle biopsy required, and what is the prognosis?
For an infant who after bag‑mask ventilation has a heart rate of 146 beats/min, blood pressure of 88/56 mmHg, oxygen saturation of 7 %, is now breathing spontaneously at 20 breaths/min but remains lethargic and only responds to painful stimuli, with a mask placed on the face and intravenous access already established, what additional interventions are indicated?
What are the causes of a D-shaped left ventricle on echocardiography?
What is the appropriate emergency department management and disposition for a patient presenting with mild hyponatremia, leukocytosis, elevated troponin I, high C‑reactive protein, glucosuria/ketonuria, and proteinuria?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.